标题
Delivery strategies in treatments of leukemia
作者
关键词
-
出版物
CHEMICAL SOCIETY REVIEWS
Volume -, Issue -, Pages -
出版商
Royal Society of Chemistry (RSC)
发表日期
2022-02-22
DOI
10.1039/d1cs00755f
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Recent advances of redox-responsive nanoplatforms for tumor theranostics
- (2021) Miaomiao Chen et al. JOURNAL OF CONTROLLED RELEASE
- Scaffold-mediated CRISPR-Cas9 delivery system for acute myeloid leukemia therapy
- (2021) Tzu-Chieh Ho et al. Science Advances
- Ferritin-based targeted delivery of arsenic to diverse leukaemia types confers strong anti-leukaemia therapeutic effects
- (2021) Changlong Wang et al. Nature Nanotechnology
- Biomimetic, Hypoxia‐Responsive Nanoparticles Overcome Residual Chemoresistant Leukemic Cells with Co‐Targeting of Therapy‐Induced Bone Marrow Niches
- (2020) Xiao Dong et al. ADVANCED FUNCTIONAL MATERIALS
- Recent Advances in the Management of Acute Lymphoblastic Leukaemia
- (2020) Katharine A. Hodby et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Recent advances in the combination delivery of drug for leukemia and other cancers
- (2020) Thikrayat Al-Attar et al. Expert Opinion on Drug Delivery
- Co-Encapsulation of Mitoxantrone and β-Elemene in Solid Lipid Nanoparticles to Overcome Multidrug Resistance in Leukemia
- (2020) Kambere Amerigos Daddy J.C. et al. Pharmaceutics
- A biomaterial-based vaccine eliciting durable tumour-specific responses against acute myeloid leukaemia
- (2020) Nisarg J. Shah et al. Nature Biomedical Engineering
- Extracellular vesicles as drug delivery systems: Why and how?
- (2020) Omnia M. Elsharkasy et al. ADVANCED DRUG DELIVERY REVIEWS
- Designing Stimuli-Responsive Upconversion Nanoparticles that Exploit the Tumor Microenvironment
- (2020) Muhammad Ovais et al. ADVANCED MATERIALS
- Chronic myeloid leukemia: 2020 update on diagnosis, therapy and monitoring
- (2020) Elias Jabbour et al. AMERICAN JOURNAL OF HEMATOLOGY
- Dual oligopeptides modification mediates arsenic trioxide containing nanoparticles to eliminate primitive chronic myeloid leukemia cells inside bone marrow niches
- (2020) Luhui Fan et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Delivery of a model lipophilic membrane cargo to bone marrow via cell-derived microparticles
- (2020) Chunyan Yang et al. JOURNAL OF CONTROLLED RELEASE
- Therapeutic vaccination against leukaemia via the sustained release of co-encapsulated anti-PD-1 and a leukaemia-associated antigen
- (2020) Xiaoling Xie et al. Nature Biomedical Engineering
- Cryo-shocked cancer cells for targeted drug delivery and vaccination
- (2020) Tianyuan Ci et al. Science Advances
- Light-Inducible Exosome-Based Vehicle for Endogenous RNA Loading and Delivery to Leukemia Cells
- (2019) Lin Huang et al. ADVANCED FUNCTIONAL MATERIALS
- Combinatorial nanocarriers against drug resistance in hematological cancers: Opportunities and emerging strategies
- (2019) Saikat Ghosh et al. JOURNAL OF CONTROLLED RELEASE
- Delivery technologies for cancer immunotherapy
- (2019) Rachel S. Riley et al. NATURE REVIEWS DRUG DISCOVERY
- Targeting the bone marrow microenvironment: a novel therapeutic strategy for pre-B acute lymphoblastic leukemia
- (2019) Rishi S. Kotecha et al. Oncotarget
- Properties of FDA-approved small molecule protein kinase inhibitors
- (2019) Robert Roskoski PHARMACOLOGICAL RESEARCH
- ENHANZE® drug delivery technology: a novel approach to subcutaneous administration using recombinant human hyaluronidase PH20
- (2019) Kenneth W. Locke et al. DRUG DELIVERY
- FDA Approval Summary: Glasdegib for newly-diagnosed acute myeloid leukemia
- (2019) Kelly J. Norsworthy et al. CLINICAL CANCER RESEARCH
- Immunoliposomes in acute myeloid leukaemia therapy. An overview of possible targets and obstacles
- (2019) Aditi Singh et al. CURRENT MEDICINAL CHEMISTRY
- Daunorubicin-containing CLL1-targeting nanomicelles have anti-leukemia stem cell activity in acute myeloid leukemia
- (2019) Tzu-yin Lin et al. Nanomedicine-Nanotechnology Biology and Medicine
- Cancer treatment and survivorship statistics, 2019
- (2019) Kimberly D. Miller et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Side effects from acute myeloid leukemia treatment: results from a national survey
- (2019) Norah L. Crossnohere et al. CURRENT MEDICAL RESEARCH AND OPINION
- Novel Targeted Nano-Parthenolide Molecule against NF-kB in Acute Myeloid Leukemia
- (2019) Noureldien H. E. Darwish et al. MOLECULES
- In vitro and in vivo effect of hyaluronic acid modified, doxorubicin and gallic acid co-delivered lipid-polymeric hybrid nano-system for leukemia therapy
- (2019) Yanping Shao et al. Drug Design Development and Therapy
- FDA Approval Summary: Calaspargase Pegol-mknl For Treatment of Acute Lymphoblastic Leukemia in Children and Young Adults
- (2019) Ruo-Jing Li et al. CLINICAL CANCER RESEARCH
- CD123/CD33 dual-antibody modified liposomes effectively target acute myeloid leukemia cells and reduce antigen-negative escape
- (2019) Shili Sun et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Expansion of primitive human hematopoietic stem cells by culture in a zwitterionic hydrogel
- (2019) Tao Bai et al. NATURE MEDICINE
- Engineered human platelet-derived microparticles as natural vectors for targeted drug delivery
- (2019) Jyotsna Kailashiya et al. Oncotarget
- CD64-targeted HO-1 RNA interference enhances chemosensitivity in orthotopic model of acute myeloid leukemia and patient-derived bone marrow cells
- (2019) Seok-Beom Yong et al. BIOMATERIALS
- The primacy of gastrointestinal tract antigen-presenting cells in lethal graft-versus-host disease
- (2019) Motoko Koyama et al. BLOOD
- An Efficient Cell-Targeting Drug Delivery System Based on Aptamer-Modified Mesoporous Silica Nanoparticles
- (2019) Yang Yang et al. Nanoscale Research Letters
- HDL-AuNPs-BMS Nanoparticle Conjugates as Molecularly Targeted Therapy for Leukemia
- (2018) Na Shen et al. ACS Applied Materials & Interfaces
- Bone Targeted Delivery of SDF-1 via Alendronate Functionalized Nanoparticles in Guiding Stem Cell Migration
- (2018) Qingchang Chen et al. ACS Applied Materials & Interfaces
- Targeting epigenetic pathway with gold nanoparticles for acute myeloid leukemia therapy
- (2018) Rong Deng et al. BIOMATERIALS
- Lanthanide-doped nanoparticles conjugated with an anti-CD33 antibody and a p53-activating peptide for acute myeloid leukemia therapy
- (2018) Fan Niu et al. BIOMATERIALS
- Targeted drug delivery for tumor therapy inside the bone marrow
- (2018) Chao-Feng Mu et al. BIOMATERIALS
- Chimeric antigen receptor–modified T cells: CD19 and the road beyond
- (2018) Alexander I. Salter et al. BLOOD
- Exosomes in acute myeloid leukemia inhibit hematopoiesis
- (2018) Michael Boyiadzis et al. CURRENT OPINION IN HEMATOLOGY
- Therapeutic journery of nitrogen mustard as alkylating anticancer agents: Historic to future perspectives
- (2018) Rajesh K. Singh et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Roles of the bone marrow niche in hematopoiesis, leukemogenesis, and chemotherapy resistance in acute myeloid leukemia
- (2018) Andi Wang et al. Hematology
- Vincristine-Loaded and sgc8-Modified Liposome as a Potential Targeted Drug Delivery System for Treating Acute Lymphoblastic Leukemia
- (2018) Siliang Duan et al. Journal of Biomedical Nanotechnology
- Hyaluronic acid-based biopharmaceutical delivery and tumor-targeted drug delivery system
- (2018) Gangliang Huang et al. JOURNAL OF CONTROLLED RELEASE
- Treating hematological malignancies with drugs inhibiting ribosome biogenesis: when and why
- (2018) Enrico Derenzini et al. Journal of Hematology & Oncology
- Past, present, and future of Bcr-Abl inhibitors: from chemical development to clinical efficacy
- (2018) Federico Rossari et al. Journal of Hematology & Oncology
- Discovery of Novel Topoisomerase II Inhibitors by Medicinal Chemistry Approaches
- (2018) Wei Hu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Targeting the bone marrow microenvironment in acute leukemia
- (2018) Christina Karantanou et al. LEUKEMIA & LYMPHOMA
- Evolution of CLL treatment — from chemoimmunotherapy to targeted and individualized therapy
- (2018) Jan A. Burger et al. Nature Reviews Clinical Oncology
- Durable Remissions with Ivosidenib in IDH1-Mutated Relapsed or Refractory AML
- (2018) Courtney D. DiNardo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
- (2018) Shannon L. Maude et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bispecific antibodies for cancer therapy: A review
- (2018) Anuradha Krishnamurthy et al. PHARMACOLOGY & THERAPEUTICS
- Design of peptide–dendrimer conjugates with tumor homing and antitumor effects
- (2018) Chie Kojima et al. RESEARCH ON CHEMICAL INTERMEDIATES
- Personalized vaccines for cancer immunotherapy
- (2018) Ugur Sahin et al. SCIENCE
- CAR T cell immunotherapy for human cancer
- (2018) Carl H. June et al. SCIENCE
- Hematopoietic stem cell transplantation in its 60s: A platform for cellular therapies
- (2018) Christian Chabannon et al. Science Translational Medicine
- Selective CXCR4+ Cancer Cell Targeting and Potent Antineoplastic Effect by a Nanostructured Version of Recombinant Ricin
- (2018) Raquel Díaz et al. Small
- Targeting murine leukemic stem cells by antibody functionalized mesoporous silica nanoparticles
- (2018) Tamoghna Mandal et al. Scientific Reports
- Formulation, Development, and In Vitro Evaluation of a CD22 Targeted Liposomal System Containing a Non-Cardiotoxic Anthracycline for B Cell Malignancies
- (2018) Nivesh Mittal et al. Pharmaceutics
- Harnessing albumin as a carrier for cancer therapies
- (2018) Ella N. Hoogenboezem et al. ADVANCED DRUG DELIVERY REVIEWS
- The potential for clinical translation of antibody-targeted nanoparticles in the treatment of acute myeloid leukaemia
- (2018) Jianfeng Guo et al. JOURNAL OF CONTROLLED RELEASE
- Nanomedicines for the treatment of hematological malignancies
- (2018) Anil K. Deshantri et al. JOURNAL OF CONTROLLED RELEASE
- Highly specific targeting of human acute myeloid leukaemia cells using pharmacologically active nanoconjugates
- (2018) Inna M. Yasinska et al. Nanoscale
- Immunotherapy in acute myeloid leukemia and myelodysplastic syndromes: The dawn of a new era?
- (2018) Yuxin Liu et al. BLOOD REVIEWS
- FDA Approval Summary: (Daunorubicin and Cytarabine) Liposome for Injection for the Treatment of Adults with High-Risk Acute Myeloid Leukemia
- (2018) Aviva C Krauss et al. CLINICAL CANCER RESEARCH
- Conjugation of haematopoietic stem cells and platelets decorated with anti-PD-1 antibodies augments anti-leukaemia efficacy
- (2018) Quanyin Hu et al. Nature Biomedical Engineering
- Platelet for drug delivery
- (2018) Yifei Lu et al. CURRENT OPINION IN BIOTECHNOLOGY
- Inotuzumab ozogamicin in relapsed B-cell acute lymphoblastic leukemia
- (2017) Swapna Thota et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Duvelisib: a phosphoinositide-3 kinase δ/γ inhibitor for chronic lymphocytic leukemia
- (2017) Hima V. Vangapandu et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Application of aptamers in treatment and diagnosis of leukemia
- (2017) Rezvan Yazdian-Robati et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Durable Molecular Remissions in Chronic Lymphocytic Leukemia Treated With CD19-Specific Chimeric Antigen Receptor–Modified T Cells After Failure of Ibrutinib
- (2017) Cameron J. Turtle et al. JOURNAL OF CLINICAL ONCOLOGY
- Nanoassemblies from amphiphilic cytarabine prodrug for leukemia targeted therapy
- (2017) Jing Liu et al. JOURNAL OF COLLOID AND INTERFACE SCIENCE
- Leukemia-specific delivery of mutant NOTCH1 targeted therapy
- (2017) Giovanni Roti et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Checkpoint inhibitors in hematological malignancies
- (2017) Chi Young Ok et al. Journal of Hematology & Oncology
- Optimizing Therapeutic Effect of Aurora B Inhibition in Acute Myeloid Leukemia with AZD2811 Nanoparticles
- (2017) Nicolas Floc'h et al. MOLECULAR CANCER THERAPEUTICS
- Strategies and challenges for the next generation of antibody–drug conjugates
- (2017) Alain Beck et al. NATURE REVIEWS DRUG DISCOVERY
- Prolonged intracellular accumulation of light-inducible nanoparticles in leukemia cells allows their remote activation
- (2017) Carlos Boto et al. Nature Communications
- Acute lymphoblastic leukemia: a comprehensive review and 2017 update
- (2017) T Terwilliger et al. Blood Cancer Journal
- Combination therapy in combating cancer
- (2017) Reza Bayat Mokhtari et al. Oncotarget
- Remission of lymphoblastic leukaemia in an intravascular fluidic environment by pliable drug carrier with a sliding target ligand
- (2017) Donghyun Jang et al. Scientific Reports
- Interleukin 3- receptor targeted exosomes inhibit in vitro and in vivo Chronic Myelogenous Leukemia cell growth
- (2017) Daniele Bellavia et al. Theranostics
- Liposomal cytarabine and daunorubicin (CPX-351) for treatment of acute myeloid leukemia
- (2017) Aaron Ronson et al. Expert Opinion on Orphan Drugs
- In situ activation of platelets with checkpoint inhibitors for post-surgical cancer immunotherapy
- (2017) Chao Wang et al. Nature Biomedical Engineering
- Human CD64-targeted non-viral siRNA delivery system for blood monocyte gene modulation
- (2017) Seok-Beom Yong et al. Scientific Reports
- Mesoporous Silica Nanoparticle-Supported Lipid Bilayers (Protocells) for Active Targeting and Delivery to Individual Leukemia Cells
- (2016) Paul N. Durfee et al. ACS Nano
- N-Heterocyclic Carbene-Gold(I) Complexes Conjugated to a Leukemia-Specific DNA Aptamer for Targeted Drug Delivery
- (2016) Weijia Niu et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- BCR-ABL-positive acute myeloid leukemia: a new entity? Analysis of clinical and molecular features
- (2016) Nina Rosa Neuendorff et al. ANNALS OF HEMATOLOGY
- Advances in understanding the acute lymphoblastic leukemia bone marrow microenvironment: From biology to therapeutic targeting
- (2016) Francesca Chiarini et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
- (2016) D. A. Arber et al. BLOOD
- Coinhibition of overexpressed genes in acute myeloid leukemia subtype M2 by gold nanoparticles functionalized with five antisense oligonucleotides and one anti-CD33(+)/CD34(+) aptamer
- (2016) M A Zaimy et al. CANCER GENE THERAPY
- Cell Cycle-Dependent Mechanisms Underlie Vincristine-Induced Death of Primary Acute Lymphoblastic Leukemia Cells
- (2016) A. Kothari et al. CANCER RESEARCH
- Allogeneic Stem Cell Transplantation: A Historical and Scientific Overview
- (2016) Anurag K. Singh et al. CANCER RESEARCH
- Driving gene-engineered T cell immunotherapy of cancer
- (2016) Laura A Johnson et al. CELL RESEARCH
- MGD011, A CD19 x CD3 Dual-Affinity Retargeting Bi-specific Molecule Incorporating Extended Circulating Half-life for the Treatment of B-Cell Malignancies
- (2016) Liqin Liu et al. CLINICAL CANCER RESEARCH
- Mechanism study of PEGylated polyester and β-cyclodextrin integrated micelles on drug resistance reversal in MRP1-overexpressed HL60/ADR cells
- (2016) Qian Ji et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Immune-related adverse events with immune checkpoint blockade: a comprehensive review
- (2016) J.M. Michot et al. EUROPEAN JOURNAL OF CANCER
- The development of agents targeting the BCR-ABL tyrosine kinase as Philadelphia chromosome-positive acute lymphoblastic leukemia treatment
- (2016) Xavier Thomas et al. Expert Opinion on Drug Discovery
- Nanomedicine approaches in acute lymphoblastic leukemia
- (2016) Andra-Sorina Tatar et al. JOURNAL OF CONTROLLED RELEASE
- Inhibition of bone loss with surface-modulated, drug-loaded nanoparticles in an intraosseous model of prostate cancer
- (2016) Isaac M. Adjei et al. JOURNAL OF CONTROLLED RELEASE
- Using Gold Nanoparticles as Delivery Vehicles for Targeted Delivery of Chemotherapy Drug Fludarabine Phosphate to Treat Hematological Cancers
- (2016) Steven Song et al. JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY
- Codelivery of Ponatinib and SAR302503 by Active Bone-Targeted Polymeric Micelles for the Treatment of Therapy-Resistant Chronic Myeloid Leukemia
- (2016) Chao-Feng Mu et al. MOLECULAR PHARMACEUTICS
- Self-assembled peptide-based nanostructures: Smart nanomaterials toward targeted drug delivery
- (2016) Neda Habibi et al. Nano Today
- Materials and methods for delivery of biological drugs
- (2016) Alexander N. Zelikin et al. Nature Chemistry
- SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia
- (2016) Constanze Schneider et al. NATURE MEDICINE
- Immunological off-target effects of imatinib
- (2016) Laurence Zitvogel et al. Nature Reviews Clinical Oncology
- Ipilimumab for Patients with Relapse after Allogeneic Transplantation
- (2016) Matthew S. Davids et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inotuzumab Ozogamicin versus Standard Therapy for Acute Lymphoblastic Leukemia
- (2016) Hagop M. Kantarjian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Enhancement of chlorpromazine antitumor activity by Pluronics F127/L81 nanostructured system against human multidrug resistant leukemia
- (2016) Joyce C de Mello et al. PHARMACOLOGICAL RESEARCH
- Aurora kinase inhibitor nanoparticles target tumors with favorable therapeutic index in vivo
- (2016) Susan Ashton et al. Science Translational Medicine
- Drug-loaded erythrocytes: on the road toward marketing approval
- (2016) Vanessa Bourgeaux et al. Drug Design Development and Therapy
- Targeted delivery of vincristine to T-cell acute lymphoblastic leukemia cells using an aptamer-modified albumin conjugate
- (2016) Seyed Mohammad Taghdisi et al. RSC Advances
- Long-Term Side Effects of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia
- (2016) Lauren Caldemeyer et al. Current Hematologic Malignancy Reports
- Exosomes: Vehicles of Intercellular Signaling, Biomarkers, and Vectors of Cell Therapy
- (2015) Stella Kourembanas Annual Review of Physiology
- Aptamer–Drug Conjugates
- (2015) Guizhi Zhu et al. BIOCONJUGATE CHEMISTRY
- Fusion Proteins for Half-Life Extension of Biologics as a Strategy to Make Biobetters
- (2015) William R. Strohl BIODRUGS
- Oligonucleotide aptamer-drug conjugates for targeted therapy of acute myeloid leukemia
- (2015) Nianxi Zhao et al. BIOMATERIALS
- Polyaptamer DNA nanothread-anchored, reduced graphene oxide nanosheets for targeted delivery
- (2015) Mi-Gyeong Kim et al. BIOMATERIALS
- PD-L1 checkpoint blockade prevents immune dysfunction and leukemia development in a mouse model of chronic lymphocytic leukemia
- (2015) F. McClanahan et al. BLOOD
- Emerging therapeutic drugs for AML
- (2015) E. M. Stein et al. BLOOD
- CD19-targeted chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia
- (2015) S. L. Maude et al. BLOOD
- Targeting of folate receptor on acute myeloid leukemia blasts with chimeric antigen receptor-expressing T cells
- (2015) R. C. Lynn et al. BLOOD
- Liposomes as nanomedical devices
- (2015) Giuseppina Bozzuto et al. International Journal of Nanomedicine
- Targeted and controlled release delivery of daunorubicin to T-cell acute lymphoblastic leukemia by aptamer-modified gold nanoparticles
- (2015) Noor Mohammad Danesh et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Immune Checkpoint Blockade in Cancer Therapy
- (2015) Michael A. Postow et al. JOURNAL OF CLINICAL ONCOLOGY
- ABT-199 (venetoclax) and BCL-2 inhibitors in clinical development
- (2015) Shundong Cang et al. Journal of Hematology & Oncology
- In vivo targeting of leukemia stem cells by directing parthenolide-loaded nanoparticles to the bone marrow niche
- (2015) H Zong et al. LEUKEMIA
- Management of adverse events associated with idelalisib treatment: expert panel opinion
- (2015) Steven E. Coutré et al. LEUKEMIA & LYMPHOMA
- Heme oxygenase-1 suppresses the apoptosis of acute myeloid leukemia cells via the JNK/c-JUN signaling pathway
- (2015) Xiaojing Lin et al. LEUKEMIA RESEARCH
- Preclinical and clinical development of inotuzumab-ozogamicin in hematological malignancies
- (2015) Boris Shor et al. MOLECULAR IMMUNOLOGY
- CD19-Targeted Nanodelivery of Doxorubicin Enhances Therapeutic Efficacy in B-Cell Acute Lymphoblastic Leukemia
- (2015) Vinu Krishnan et al. MOLECULAR PHARMACEUTICS
- CD33-Targeted Lipid Nanoparticles (aCD33LNs) for Therapeutic Delivery of GTI-2040 to Acute Myelogenous Leukemia
- (2015) Hong Li et al. MOLECULAR PHARMACEUTICS
- Self-assembled multifunctional DNA nanoflowers for the circumvention of multidrug resistance in targeted anticancer drug delivery
- (2015) Lei Mei et al. Nano Research
- A new approach for the treatment of CLL using chlorambucil/hydroxychloroquine-loaded anti-CD20 nanoparticles
- (2015) Sara Capolla et al. Nano Research
- Acute Myeloid Leukemia
- (2015) Hartmut Döhner et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia
- (2015) Jan A. Burger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tetraspanin CD82 regulates bone marrow homing of acute myeloid leukemia by modulating the molecular organization of N-cadherin
- (2015) K D Marjon et al. ONCOGENE
- Daunorubicin-Loaded DNA Origami Nanostructures Circumvent Drug-Resistance Mechanisms in a Leukemia Model
- (2015) Patrick D. Halley et al. Small
- Stimuli-responsive terpolymer mPEG-b-PDMAPMA-b-PAH mediated co-delivery of adriamycin and siRNA to enhance anticancer efficacy
- (2015) Minghui Xu et al. RSC Advances
- Antibody-Drug Conjugates: An Emerging Concept in Cancer Therapy
- (2014) Ravi V. J. Chari et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Idelalisib, an inhibitor of phosphatidylinositol 3-kinase p110 , for relapsed/refractory chronic lymphocytic leukemia
- (2014) J. R. Brown et al. BLOOD
- A phase 1 study of the PI3K inhibitor idelalisib in patients with relapsed/refractory mantle cell lymphoma (MCL)
- (2014) B. S. Kahl et al. BLOOD
- Targeted therapy with MXD3 siRNA, anti-CD22 antibody and nanoparticles for precursor B-cell acute lymphoblastic leukaemia
- (2014) Noriko Satake et al. BRITISH JOURNAL OF HAEMATOLOGY
- Addition of gemtuzumab ozogamicin to induction chemotherapy in adult patients with acute myeloid leukaemia: a meta-analysis of individual patient data from randomised controlled trials
- (2014) Robert K Hills et al. LANCET ONCOLOGY
- Tumor antigen ROR1 targeted drug delivery mediated selective leukemic but not normal B-cell cytotoxicity in chronic lymphocytic leukemia
- (2014) R Mani et al. LEUKEMIA
- Development of Synthetic Peptide-Modified Liposomes with LDL Receptor Targeting Capacity and Improved Anticancer Activity
- (2014) Mei Liu et al. MOLECULAR PHARMACEUTICS
- Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
- (2014) Shannon L. Maude et al. NEW ENGLAND JOURNAL OF MEDICINE
- Preserving Catalytic Activity and Enhancing Biochemical Stability of the Therapeutic Enzyme Asparaginase by Biocompatible Multilayered Polyelectrolyte Microcapsules
- (2013) Christos S. Karamitros et al. BIOMACROMOLECULES
- Targeted drug delivery and cross-linking induced apoptosis with anti-CD37 based dual-ligand immunoliposomes in B chronic lymphocytic leukemia cells
- (2013) Bo Yu et al. BIOMATERIALS
- Nuclear localization of P-glycoprotein is responsible for protection of the nucleus from doxorubicin in the resistant LoVo cell line
- (2013) Witold Szaflarski et al. BIOMEDICINE & PHARMACOTHERAPY
- Stage I of a phase 2 study assessing the efficacy, safety, and tolerability of barasertib (AZD1152) versus low-dose cytosine arabinoside in elderly patients with acute myeloid leukemia
- (2013) Hagop M. Kantarjian et al. CANCER
- Older and new purine nucleoside analogs for patients with acute leukemias
- (2013) Pawel Robak et al. CANCER TREATMENT REVIEWS
- Nanoparticles Engineered with Rituximab and Loaded with Nutlin-3 Show Promising Therapeutic Activity in B-Leukemic Xenografts
- (2013) R. Voltan et al. CLINICAL CANCER RESEARCH
- Acute lymphoblastic leukaemia
- (2013) Hiroto Inaba et al. LANCET
- Extracellular vesicles: biology and emerging therapeutic opportunities
- (2013) Samir EL Andaloussi et al. NATURE REVIEWS DRUG DISCOVERY
- Photosensitizer-Gold Nanorod Composite for Targeted Multimodal Therapy
- (2013) Jian Wang et al. Small
- Transferrin as a drug carrier: Cytotoxicity, cellular uptake and transport kinetics of doxorubicin transferrin conjugate in the human leukemia cells
- (2013) Marzena Szwed et al. TOXICOLOGY IN VITRO
- Enzyme-responsive nanoparticles for drug release and diagnostics
- (2012) Roberto de la Rica et al. ADVANCED DRUG DELIVERY REVIEWS
- Milatuzumab-Conjugated Liposomes as Targeted Dexamethasone Carriers for Therapeutic Delivery in CD74+ B-cell Malignancies
- (2012) Y. Mao et al. CLINICAL CANCER RESEARCH
- Pharmacology of dimethanesulfonate alkylating agents: busulfan and treosulfan
- (2012) Ariane Galaup et al. Expert Opinion on Drug Metabolism & Toxicology
- Tyrosine kinase inhibitors in acute and chronic leukemias
- (2012) Maro Ohanian et al. EXPERT OPINION ON PHARMACOTHERAPY
- Protein-based nanocarriers as promising drug and gene delivery systems
- (2012) Ahmed O. Elzoghby et al. JOURNAL OF CONTROLLED RELEASE
- p53 protein expression in chronic lymphocytic leukemia
- (2012) Ludger Sellmann et al. LEUKEMIA & LYMPHOMA
- Pharmacokinetics of CPX-351; a nano-scale liposomal fixed molar ratio formulation of cytarabine:daunorubicin, in patients with advanced leukemia
- (2012) E.J. Feldman et al. LEUKEMIA RESEARCH
- Delivery of chemotherapeutic drugs in tumour cell-derived microparticles
- (2012) Ke Tang et al. Nature Communications
- Erythrocyte-Inspired Delivery Systems
- (2012) Che-Ming J. Hu et al. Advanced Healthcare Materials
- E-Selectin-Targeted Porous Silicon Particle for Nanoparticle Delivery to the Bone Marrow
- (2011) Aman P. Mann et al. ADVANCED MATERIALS
- From an old remedy to a magic bullet: molecular mechanisms underlying the therapeutic effects of arsenic in fighting leukemia
- (2011) S.-J. Chen et al. BLOOD
- Antibody-Drug Conjugates of Calicheamicin Derivative: Gemtuzumab Ozogamicin and Inotuzumab Ozogamicin
- (2011) A. D. Ricart CLINICAL CANCER RESEARCH
- Leukemia Stem Cells and Microenvironment: Biology and Therapeutic Targeting
- (2011) Marina Y. Konopleva et al. JOURNAL OF CLINICAL ONCOLOGY
- Bone metastasis targeting: A novel approach to reach bone using Zoledronate anchored PLGA nanoparticle as carrier system loaded with Docetaxel
- (2011) Kiran Ramanlal Chaudhari et al. JOURNAL OF CONTROLLED RELEASE
- State of the art in PEGylation: The great versatility achieved after forty years of research
- (2011) Gianfranco Pasut et al. JOURNAL OF CONTROLLED RELEASE
- Omacetaxine may have a role in chronic myeloid leukaemia eradication through downregulation of Mcl-1 and induction of apoptosis in stem/progenitor cells
- (2011) E K Allan et al. LEUKEMIA
- Characterization of high-affinity peptides and their feasibility for use in nanotherapeutics targeting leukemia stem cells
- (2011) Hongyong Zhang et al. Nanomedicine-Nanotechnology Biology and Medicine
- The bone marrow microenvironment and leukemia: biology and therapeutic targeting
- (2011) Edward Allan R Sison et al. Expert Review of Hematology
- P-Glycoprotein Antibody Functionalized Carbon Nanotube Overcomes the Multidrug Resistance of Human Leukemia Cells
- (2010) Ruibin Li et al. ACS Nano
- Surface antigens analysis reveals significant expression of candidate targets for immunotherapy in adult acute lymphoid leukemia
- (2010) Pier Paolo Piccaluga et al. LEUKEMIA & LYMPHOMA
- BCR-ABL tyrosine kinase inhibitors in the treatment of Philadelphia chromosome positive chronic myeloid leukemia: A review
- (2010) Xin An et al. LEUKEMIA RESEARCH
- Metronomic chemotherapy: new rationale for new directions
- (2010) Eddy Pasquier et al. Nature Reviews Clinical Oncology
- Delivering nanomedicine to solid tumors
- (2010) Rakesh K. Jain et al. Nature Reviews Clinical Oncology
- Polymeric carriers: Preclinical safety and the regulatory implications for design and development of polymer therapeutics
- (2009) Rogério Gaspar et al. ADVANCED DRUG DELIVERY REVIEWS
- Molecular Assembly of an Aptamer-Drug Conjugate for Targeted Drug Delivery to Tumor Cells
- (2009) Yu-Fen Huang et al. CHEMBIOCHEM
- Therapeutic targeting of microenvironmental interactions in leukemia: Mechanisms and approaches
- (2009) Marina Konopleva et al. DRUG RESISTANCE UPDATES
- Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer
- (2009) Paula J. Bates et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- L-Asparaginase encapsulated intact erythrocytes for treatment of acute lymphoblastic leukemia (ALL)
- (2009) Young Min Kwon et al. JOURNAL OF CONTROLLED RELEASE
- Contribution of bone microenvironment to leukemogenesis and leukemia progression
- (2009) F Ayala et al. LEUKEMIA
- The DNA methyltransferase inhibitors azacitidine, decitabine and zebularine exert differential effects on cancer gene expression in acute myeloid leukemia cells
- (2009) C Flotho et al. LEUKEMIA
- Bendamustine (Treanda) Displays a Distinct Pattern of Cytotoxicity and Unique Mechanistic Features Compared with Other Alkylating Agents
- (2008) L. M. Leoni et al. CLINICAL CANCER RESEARCH
- The Bone Marrow Microenvironment as a Tumor Sanctuary and Contributor to Drug Resistance
- (2008) M. B. Meads et al. CLINICAL CANCER RESEARCH
- Phase I Safety and Pharmacokinetic Study of CT-011, a Humanized Antibody Interacting with PD-1, in Patients with Advanced Hematologic Malignancies
- (2008) R. Berger et al. CLINICAL CANCER RESEARCH
- Targeted drug delivery via folate receptors
- (2008) Xiaobin Zhao et al. Expert Opinion on Drug Delivery
- CXCR4 antagonists: targeting the microenvironment in leukemia and other cancers
- (2008) J A Burger et al. LEUKEMIA
- In vivo maintenance of synergistic cytarabine:daunorubicin ratios greatly enhances therapeutic efficacy
- (2008) Paul Tardi et al. LEUKEMIA RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now